MedTrace Logo

ZIPPER™ Stent-Graft Trial for Aortic Arch Dissection

NCT07170332 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 127

Last updated 2025-09-15

No results posted yet for this study

Summary

This study is the feasible study on a new technique of ZIPPER aortic arch stentgraft system

Conditions

  • Dissection of Aortic Arch

Interventions

DEVICE

ZIPPER™ Stent-Graft Trial for Aortic Arch Dissection

The ZIPPER aortic arch stentgraft system consists of the arch mainbody stentgraft system, the branch artery stentgraft system and the thoracic extension stentgraft system.

Sponsors & Collaborators

  • Hangzhou Endonom Medtech Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-30
Primary Completion
2027-09-30
Completion
2032-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07170332 on ClinicalTrials.gov